TMDX
TransMedics Group, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$89.98
+3.45%Aug 23, 2026, 08:29 UTC
Emerald Investment Advisers LLC acquired a new stake of 30,456 shares in TransMedics Group, Inc. during the quarter, valued at approximately $2,023,000, as disclosed to the SEC.
Source:Aug 18, 2026, 05:03 UTC
TransMedics Group outlined its growth strategy at Canaccord Genuity's 46th Annual Global Growth Conference, highlighting investments in kidney transplantation, European expansion, next-generation technology, and broader adoption in heart and lung transplantation.
Source:Aug 17, 2026, 14:26 UTC
Kahn Swick & Foti, LLC initiated an investigation into the officers and directors of TransMedics Group, Inc.
Aug 5, 2026, 05:30 UTC
TransMedics launched a new donor and recipient screening coordination service on July 1, 2026, with a major Boston healthcare system.
Source:Aug 4, 2026, 20:05 UTC
TransMedics Group reported its financial results for the quarter ended June 30, 2026, on August 4, 2026.
Aug 3, 2026, 20:05 UTC
TransMedics Group granted non-qualified stock options for 18,762 shares and 12,414 restricted stock units to 9 new employees as inducement grants on July 29, 2026.
Source:Jul 6, 2026, 11:05 UTC
TransMedics Group completed a strategic investment in PAD Aviation service GmbH.
Source: